Former President Donald Trump used an op-ed from the New York Post to attack the Biden administration on Friday night for allowing a break on Johnson & Johnson’s coronavirus vaccine and accusing them of “ leaving the show ‘insanely risk-averse bureaucrats. lead’.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) announced the break from vaccine use Tuesday morning, citing six cases of women with cerebral sinus venous thrombosis in combination with thrombocytopenia, a rare brain blood clot.
On Friday night, the former president sent an email in which he literally reiterated the arguments of the New York Post editors that the cases were rare enough not to hinder the introduction of the vaccine, calling the step “ pure madness. ” .
“The federal pause in J & J’s recording makes no sense,” the statement said.
Why is Biden’s White House letting insanely risk-averse bureaucrats run the show? Only six of the nearly 7 million people who received the Johnson & Johnson vaccine reported blood clots, ”the statement said.
“The condition is more common in the general population, and any vaccine – indeed, any drug – carries some risk, including the Moderna and Pfizer shots.
“With COVID cases still on the rise nationwide, it is sheer madness to delay millions of vaccinations and feed the fears among the vax-resistant. Indeed, this crazy movement is a gift to the anti-vax movement: the scientific bureaucrats are feeding that deranged pseudoscience. “
While the pause in use of the J&J shot would initially only last a few days, the CDC’s Advisory Committee on Immunization (ACIP) decided on Wednesday that the pause should remain in effect until the panel resumes in seven to 10 days. meets.
The Biden administration has defended the break, arguing that it is the right precaution to protect Americans.
“Science moves at the speed of science and they want to look at more data. We believe they are the gold standard, the [Food and Drug Administration] FDA is the gold standard in the world, ”said White House press secretary Jen Psaki Thursday.
“Actually, their thorough and transparent approach should give the American public extra confidence in the role they play and the approach the United States is taking in approving vaccines on the market.”
